These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 27207154

  • 1. Benzylpiperazine: "A messy drug".
    Katz DP, Deruiter J, Bhattacharya D, Ahuja M, Bhattacharya S, Clark CR, Suppiramaniam V, Dhanasekaran M.
    Drug Alcohol Depend; 2016 Jul 01; 164():1-7. PubMed ID: 27207154
    [Abstract] [Full Text] [Related]

  • 2. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Neuropsychopharmacology; 2005 Mar 01; 30(3):550-60. PubMed ID: 15496938
    [Abstract] [Full Text] [Related]

  • 3. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL, Katz EB, Coop A, Fantegrossi WE.
    Pharmacol Biochem Behav; 2007 Nov 01; 88(1):18-27. PubMed ID: 17651790
    [Abstract] [Full Text] [Related]

  • 4. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Ann N Y Acad Sci; 2004 Oct 01; 1025():189-97. PubMed ID: 15542717
    [Abstract] [Full Text] [Related]

  • 5. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P.
    Clin Toxicol (Phila); 2011 Mar 01; 49(3):131-41. PubMed ID: 21495881
    [Abstract] [Full Text] [Related]

  • 6. Clinical toxicology of newer recreational drugs.
    Hill SL, Thomas SH.
    Clin Toxicol (Phila); 2011 Oct 01; 49(8):705-19. PubMed ID: 21970769
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
    Lee H, Wang GY, Curley LE, Sollers JJ, Kydd RR, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2016 Mar 01; 233(5):863-71. PubMed ID: 26630992
    [Abstract] [Full Text] [Related]

  • 8. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ, Vorce SP, Holler JM, Lyons TP.
    J Anal Toxicol; 2010 Oct 01; 34(8):464-9. PubMed ID: 21819791
    [Abstract] [Full Text] [Related]

  • 9. Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine.
    Katz DP, Majrashi M, Ramesh S, Govindarajulu M, Bhattacharya D, Bhattacharya S, Shlghom A, Bradford C, Suppiramaniam V, Deruiter J, Clark CR, Dhanasekaran M.
    Toxicol Mech Methods; 2018 Mar 01; 28(3):177-186. PubMed ID: 28874085
    [Abstract] [Full Text] [Related]

  • 10. Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).
    Curley LE, Kydd RR, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2013 Oct 01; 229(4):673-85. PubMed ID: 23666554
    [Abstract] [Full Text] [Related]

  • 11. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
    J Med Toxicol; 2008 Dec 01; 4(4):254-7. PubMed ID: 19031377
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
    Curley LE, Kydd RR, Robertson MC, Pillai A, McNair N, Lee H, Kirk IJ, Russell BR.
    Psychopharmacology (Berl); 2015 Aug 01; 232(16):2969-80. PubMed ID: 25893641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M.
    Swiss Med Wkly; 2015 Aug 01; 145():w14043. PubMed ID: 25588018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
    Gee P, Jerram T, Bowie D.
    Clin Toxicol (Phila); 2010 Mar 01; 48(3):230-3. PubMed ID: 20184432
    [Abstract] [Full Text] [Related]

  • 18. Partying on? Life after BZP-based party pills.
    Green JA.
    N Z Med J; 2008 Oct 03; 121(1283):35-42. PubMed ID: 18841183
    [Abstract] [Full Text] [Related]

  • 19. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
    Lecompte Y, Roussel O, Perrin M.
    Ann Pharm Fr; 2008 Mar 03; 66(2):85-91. PubMed ID: 18570904
    [Abstract] [Full Text] [Related]

  • 20. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nishikawa M, Nakajima K, Tsuchihashi H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May 25; 819(2):315-22. PubMed ID: 15833296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.